BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30686085)

  • 1. Circulating Long Noncoding RNA LIPCAR Predicts Heart Failure Outcomes in Patients Without Chronic Kidney Disease.
    Santer L; López B; Ravassa S; Baer C; Riedel I; Chatterjee S; Moreno MU; González A; Querejeta R; Pinet F; Thum T; Díez J
    Hypertension; 2019 Apr; 73(4):820-828. PubMed ID: 30686085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LIPCAR Is Increased in Chronic Symptomatic HF Patients. A Sub-Study of the GISSI-HF Trial.
    Meessen JMTA; Bär C; di Dona FM; Staszewsky LI; Di Giulio P; Di Tano G; Costa A; Leonardy J; Novelli D; Nicolis EB; Masson S; Pinet F; Thum T; Latini R
    Clin Chem; 2021 Nov; 67(12):1721-1731. PubMed ID: 34751777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating LIPCAR is a potential biomarker of heart failure in patients post-acute myocardial infarction.
    Yan L; Zhang Y; Wang M; Wang L; Zhang W; Ge ZR
    Exp Biol Med (Maywood); 2021 Dec; 246(24):2589-2594. PubMed ID: 34365838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure.
    Kumarswamy R; Bauters C; Volkmann I; Maury F; Fetisch J; Holzmann A; Lemesle G; de Groote P; Pinet F; Thum T
    Circ Res; 2014 May; 114(10):1569-75. PubMed ID: 24663402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart failure with anemia: novel findings on the roles of renal disease, interleukins, and specific left ventricular remodeling processes.
    O'Meara E; Rouleau JL; White M; Roy K; Blondeau L; Ducharme A; Neagoe PE; Sirois MG; Lavoie J; Racine N; Liszkowski M; Madore F; Tardif JC; de Denus S;
    Circ Heart Fail; 2014 Sep; 7(5):773-81. PubMed ID: 25027873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of chronic kidney disease with abnormal cardiac mechanics and adverse outcomes in patients with heart failure and preserved ejection fraction.
    Unger ED; Dubin RF; Deo R; Daruwalla V; Friedman JL; Medina C; Beussink L; Freed BH; Shah SJ
    Eur J Heart Fail; 2016 Jan; 18(1):103-12. PubMed ID: 26635076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. sST2 as a New Biomarker of Chronic Kidney Disease-Induced Cardiac Remodeling: Impact on Risk Prediction.
    Plawecki M; Morena M; Kuster N; Chenine L; Leray-Moragues H; Jover B; Fesler P; Lotierzo M; Dupuy AM; Klouche K; Cristol JP
    Mediators Inflamm; 2018; 2018():3952526. PubMed ID: 30402040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The associations among co-morbidity, cardiac geometries and mechanics in hospitalized heart failure with or without preserved ejection fraction.
    Lo CI; Lai YH; Chang SN; Kuo JY; Hsieh YC; Bulwer BE; Hung CL; Yeh HI
    Clin Exp Hypertens; 2017; 39(5):473-480. PubMed ID: 28569600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiorenal interaction and heart failure outcomes. A role for insulin-like growth factor binding protein 2?
    Ravassa S; Beaumont J; Cediel G; Lupón J; López B; Querejeta R; Díez J; Bayés-Genís A; González A
    Rev Esp Cardiol (Engl Ed); 2020 Oct; 73(10):835-843. PubMed ID: 31948893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNA-132 levels improve risk prediction for heart failure hospitalization in patients with chronic heart failure.
    Masson S; Batkai S; Beermann J; Bär C; Pfanne A; Thum S; Magnoli M; Balconi G; Nicolosi GL; Tavazzi L; Latini R; Thum T
    Eur J Heart Fail; 2018 Jan; 20(1):78-85. PubMed ID: 29027324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiological impact of serum fibroblast growth factor 23 in patients with nonischemic cardiac disease and early chronic kidney disease.
    Imazu M; Takahama H; Asanuma H; Funada A; Sugano Y; Ohara T; Hasegawa T; Asakura M; Kanzaki H; Anzai T; Kitakaze M
    Am J Physiol Heart Circ Physiol; 2014 Nov; 307(10):H1504-11. PubMed ID: 25217649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LIPCAR levels in plasma-derived extracellular vesicles is associated with left ventricle remodeling post-myocardial infarction.
    Turkieh A; Beseme O; Saura O; Charrier H; Michel JB; Amouyel P; Thum T; Bauters C; Pinet F
    J Transl Med; 2024 Jan; 22(1):31. PubMed ID: 38184604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.
    Lupón J; Díez-López C; de Antonio M; Domingo M; Zamora E; Moliner P; González B; Santesmases J; Troya MI; Bayés-Genís A
    Eur J Heart Fail; 2017 Dec; 19(12):1615-1623. PubMed ID: 28387002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal function largely influences Galectin-3 prognostic value in heart failure.
    Zamora E; Lupón J; de Antonio M; Galán A; Domingo M; Urrutia A; Troya M; Bayes-Genis A
    Int J Cardiol; 2014 Nov; 177(1):171-7. PubMed ID: 25499371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of glomerular filtration rate estimation equations in acute heart failure with preserved versus reduced ejection fraction.
    Casado Cerrada J; Carrasco Sánchez FJ; Pérez-Calvo JI; Manzano L; Formiga F; Aramburu Bodas O; Conde A; Quirós R; Pérez Bocanegra C; Montero-Pérez-Barquero M;
    Int J Clin Pract; 2015 Aug; 69(8):829-39. PubMed ID: 25651522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of left ventricular systolic dysfunction in pre-dialysis and dialysis patients with preserved left ventricular ejection fraction.
    Hensen LCR; Goossens K; Delgado V; Abou R; Rotmans JI; Jukema JW; Bax JJ
    Eur J Heart Fail; 2018 Mar; 20(3):560-568. PubMed ID: 29164753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased plasma levels of lncRNA H19 and LIPCAR are associated with increased risk of coronary artery disease in a Chinese population.
    Zhang Z; Gao W; Long QQ; Zhang J; Li YF; Liu DC; Yan JJ; Yang ZJ; Wang LS
    Sci Rep; 2017 Aug; 7(1):7491. PubMed ID: 28790415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acutely decompensated heart failure with preserved and reduced ejection fraction present with comparable haemodynamic congestion.
    Van Aelst LNL; Arrigo M; Placido R; Akiyama E; Girerd N; Zannad F; Manivet P; Rossignol P; Badoz M; Sadoune M; Launay JM; Gayat E; Lam CSP; Cohen-Solal A; Mebazaa A; Seronde MF
    Eur J Heart Fail; 2018 Apr; 20(4):738-747. PubMed ID: 29251818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of Circulating Extracellular RNAs With Myocardial Remodeling and Heart Failure.
    Shah RV; Rong J; Larson MG; Yeri A; Ziegler O; Tanriverdi K; Murthy V; Liu X; Xiao C; Pico AR; Huan T; Levy D; Lewis GD; Rosenzweig A; Vasan RS; Das S; Freedman JE
    JAMA Cardiol; 2018 Sep; 3(9):871-876. PubMed ID: 30090932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.